Vascular endothelial growth factor expression induced by proinflammatory cytokines (interleukin 1α, β) in cells of the human pilosebaceous unit

Dermatology

Volumn 196, Issue 1, 1998, Pages 89-92

  Kozlowska, Urszula ^a,b   Blume Peytavi, U ^a   Kodelja, V ^a   Sommer, C ^a   Goerdt, S ^a   Jablonska, S ^b   Orfanos, C E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Interleukin 1; Pilosebaceous unit; Vascular endothelial growth factor; Vascular permeability factor

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ACNE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; SEBACEOUS GLAND;

CELLS, CULTURED; ENDOTHELIAL GROWTH FACTORS; HAIR FOLLICLE; HUMANS; INTERLEUKIN-1; KERATINOCYTES; LYMPHOKINES; POLYMERASE CHAIN REACTION; SEBACEOUS GLANDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031905663     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017878     Document Type: Conference Paper

References (22)

1. Ingham E, Eady EA, Goodwin CE, Cove JH, Cunliffe WJ: Pro-inflammatory levels of interleukin-1α-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 1992;98:895-901.
2. Eady EA, Ingham E, Walters CE, Cove JH, Cunliffe WJ: Modulation of comedonal levels of interleukin-1 in acne patients treated with tetracyclines. J Invest Dermatol 1993;101:86-91.
3. Kupper TS: Immune and inflammatory processes in cutaneous tissues: Mechanisms and speculations. J Clin Invest 1990;86:1783-1789.
4. Kupper TS, Groves RW: The interleukin-1 axis and cutaneous inflammation. J Invest Dermatol 1995;105:62S-66S.
5. Dinarello CA: Biology of interleukin 1. FASEB J 1988;2:108-115.
6. Kupper TS, Lee F, Birchall N, Clark S, Dower SK: Interleukin binds to specific receptors on human keratinocytes and induces granulocyte macrophage colony stimulating factors and mRNA and protein. J Clin Invest 1988;82:1787-1792.
7. Groves RW, Rauschmayr T, Nakamura K, Sarkar S, Williams IR, Kupper TS: Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type 1) on epidermal keratinocytes: Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease. J Clin Invest 1996;98:336-344.
8. Detmar M: Molecular regulation of angiogenesis in the skin (editorial). J Invest Dermatol 1996;106:207-208.
9. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YCE, Olander JV, Collony DT, Stem D: Vascular permeability factor, a tumor derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990;172:1535-1546.
10. Clauss M, Weich H, Breier G, Knies U, Röckl W, Waltenberger J, Risau W: The vascular endothelial growth factor receptor Flt-1 mediates biological activities: Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 1996;271:17629-17634.
11. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marmé D: Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996;87:3336-3343.
12. Jahoda CAB, Oliver RF: Vibrissa dermal papilla cell aggregative behaviour in vivo and in vitro. J Embryol Exp Morphol 1984;79:211-224.
13. Detmar M, Schaart FM, Blume U, Orfanos CE: Culture of hair matrix and follicular keratinocytes. J Invest Dermatol 1993;101:130S-134S.
14. Ballaun C, Weninger W, Uthman A, Weich H, Tschachler E: Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol 1995;104:7-10.
15. Schön MP, Schön M, Klein C, Blume U, Bisson S, Orfanos CE: Carcinoma-associated antigen MH 99/KS 1/4 is related to proliferation and age of transformed epithelial cell lines. J Invest Dermatol 1994;102:987-991.
16. Detmar M, Brown L, Claffey KP, Yeo K, Kocher O, Jackman RW, Berse B, Dvorak H: Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994;180:1141-1146.
17. Brown L, Harrist T, Yeo K, Stahle-Backdahl M, Jackman RW, Berse B, Tognazzi K, Dvorak HF, Detmar M: Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol 1995;104:744-749.
18. Brown L, Yeo K, Berse B, Yeo T. Senger DR, Dvorak HF, Van de Water L: Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992;176:1375-1379.
19. Li J, Perrella MA, Tsai J-C, Yet S-F, Hsieh C-M, Yoshizumi M, Patterson C, Endege WO, Zhou F, Lee M-E: Induction of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells. J Biol Chem 1995;270:308-312.
20. Frank S, Hubner G, Breier G, Longaker M, Greenhalgh DG, Werner S: Regulation of vascular endothelial growth factor expression in cultured keratinocytes: Implications for normal and impaired wound healing. J Biol Chem 1995;270:12607-12613.
21. Cornali E, Zietz C, Benelli R, Weninger W, Masiello L, Breier G, Tschachler E, Albini A, Sturzl M: Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J Pathol 1996;149:1851-1869.
22. Groves RW, Mizutani H, Kieffer JD, Kupper TS: Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis. Proc Natl Acad Sci USA 1995;92:11874-11878.